Related Experiment Video
Updated: Jul 4, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Venous Thromboembolism and Associated Factors in Hospitalized Patients with COVID-19 at Addis Ababa COVID-19 Field
Abel Teklit Haile1,2, Robel Gemechu Haile1,2,3, Esrom Hagos Gebrehiwot1,2,3
1Research Department, Saint Peter Specialized Hospital, Addis Ababa, Ethiopia.
Insights
COVID-19 patients face increased risks of venous thromboembolism (VTE). Factors like severe illness, diabetes, hypertension, and prior VTE risk significantly elevate this danger, highlighting the need for vigilant monitoring and anticoagulation strategies.
Area of Science:
- Infectious Diseases
- Cardiology
- Hematology
Background:
- COVID-19 has been linked to an increased incidence of thrombotic events.
- Emerging evidence suggests a predisposition to venous thromboembolism (VTE) in individuals infected with SARS-CoV-2.
- This study investigated VTE and its associated factors in COVID-19 patients at a field hospital in Addis Ababa.
Purpose of the Study:
- To identify factors associated with the development of thromboembolism in patients diagnosed with COVID-19.
- To assess the risks and contributing elements for VTE in hospitalized COVID-19 patients.
Main Methods:
- An institution-based case-control study was conducted.
- Data analysis involved SPSS version 26 and multivariable binary logistic regression.
Main Results:
- Severe COVID-19 cases (AOR=0.38) showed a reduced association with VTE, while pre-existing VTE risk factors (AOR=2.57) increased it.
- Diabetes (AOR=3.745), chest pain (AOR=4.13), stage 1 hypertension (AOR=3.67), and hospital anticoagulation (AOR=11.78) were significantly associated with VTE development.
- The odds of VTE were substantially higher in patients receiving hospital anticoagulation.
Conclusions:
- A direct association exists between severe COVID-19 and factors including diabetes, pre-existing VTE risk, hypertension, and hospital anticoagulation.
- These findings underscore the complex interplay between COVID-19 severity, comorbidities, and thrombotic risk.
- Effective management strategies for VTE in COVID-19 patients are crucial.
Background:
The association of COVID-19 with venous thromboembolism is of particular interest as there are reports that have associated thrombotic events with the pandemic. COVID-19 may predispose to venous thromboembolism. There is initial evidence suggesting that individuals with COVID-19 may be more prone to developing venous thromboembolism (VTE). This study aims to assess venous thromboembolism and associated factors in 19 patients admitted to Addis Ababa's field hospital for COVID-19.
Objective:
To identify associated factors that affect the development of thromboembolism in patients admitted with the diagnosis of COVID-19.
Methods:
To determine the risks of VTE patients, an institution-based case control research was conducted using SPSS version 26, multivariable binary logistic regression analysis was used.
Results:
Significant factors associated with the development of VTE in COVID-19 patients included having a severe case (AOR = 0.38, 95% CI = 0.149-0.961), risk factors for VTE (AOR = 2.57, 95% CI = 1.18-5.33), diabetes (AOR = 3.745, 95% CI = 1.715-8.176), chest pain (AOR = 4.13, 95% CI = 1.89-9), stage 1 hypertension levels (AOR = 3.67, 95% CI = 1.37-9.836), and hospital anticoagulation (AOR = 11.78, 95% CI = 5.25-26.4).
Conclusion:
The results of VTE in individuals with COVID-19 imply a direct association between severe COVID-19 and diabetes, having risk factors, hypertension, and hospital anticoagulation.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pneumonia III: Complications and Assessment
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

